CoreWeave (NASDAQ:CRWV) versus ChronoScale Corporation Common Stock (NASDAQ:CHRN) Head-To-Head Analysis

CoreWeave (NASDAQ:CRWV) and ChronoScale Corporation Common Stock (NASDAQ:CHRN) are both technology companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for CoreWeave and ChronoScale Corporation Common Stock, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CoreWeave	3	10	21	0	2.53
ChronoScale Corporation Common Stock	1	1	0	0	1.50

CoreWeave currently has a consensus price target of $141.90, suggesting a potential upside of 67.16%. ChronoScale Corporation Common Stock has a consensus price target of $6.00, suggesting a potential downside of 67.00%. Given CoreWeave’s stronger consensus rating and higher possible upside, equities analysts clearly believe CoreWeave is more favorable than ChronoScale Corporation Common Stock.

Profitability

This table compares CoreWeave and ChronoScale Corporation Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CoreWeave	-25.41%	-47.95%	-3.79%
ChronoScale Corporation Common Stock	-135.66%	-197.81%	-74.17%

Valuation & Earnings

This table compares CoreWeave and ChronoScale Corporation Common Stock”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CoreWeave	$5.13 billion	7.59	-$1.17 billion	($3.65)	-23.26
ChronoScale Corporation Common Stock	$12.80 million	206.85	-$11.69 million	($5.38)	-3.38

ChronoScale Corporation Common Stock has lower revenue, but higher earnings than CoreWeave. CoreWeave is trading at a lower price-to-earnings ratio than ChronoScale Corporation Common Stock, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

6.4% of ChronoScale Corporation Common Stock shares are owned by institutional investors. 24.2% of CoreWeave shares are owned by insiders. Comparatively, 6.9% of ChronoScale Corporation Common Stock shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

CoreWeave has a beta of 7.45, indicating that its share price is 645% more volatile than the S&P 500. Comparatively, ChronoScale Corporation Common Stock has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.

Summary

CoreWeave beats ChronoScale Corporation Common Stock on 10 of the 14 factors compared between the two stocks.

About CoreWeave

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.